VivoSeq
Other

Occlusion

1

Pipeline Programs↗

3

Active Trials↗

3

Companies Involved↗

Occlusion is an early-stage landscape with 1 program across 3 companies. The most active players are Grifols Therapeutics LLC, Matrizyme Pharma Corporation, International Dental Contiuing Education.

Intelligence

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

90/100

Attrition Rate

6/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Grifols Therapeutics LLC logo

Grifols Therapeutics LLC

0 programs

PreclinicalM

Matrizyme Pharma Corporation

0 programs

PreclinicalI

International Dental Contiuing Education

0 programs

Preclinical

Pipeline

Programs by Phase

Preclinical1

Standard Pharmacological Treatment

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Approved
No programs

Analysis

Trial Status

34

clinical trials

Completed19 · 56%
Unknown status10 · 29%
Terminated2 · 6%
Recruiting2 · 6%
Not yet recruiting1 · 3%

Clinical Trials

Trial Activity

34 trials

Effect of PCI on Clinical Prognosis of Chronic Coronary Artery Occlusion
Recruiting·TThe First Affiliated Hospital with Nanjing Medical University·N/A·NCT06542653·258 enrolled
Radial Access Data in Vascular Interventions: A Prospective Observational Registry Study
Recruiting·MMersin Medicalpark Hastanesi·N/A·NCT07614386·20,000 enrolled
Endovascular Treatment of Chronic Intracranial Artery Occlusion: A Multicenter Randomized Controlled Trial
Not yet recruiting·UUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology·Preclinical·NCT07699003·382 enrolled
PROTon Pump Inhibitors and Stent OCclusion Rate Of Lumen Apposing Metal Stents
Completed·UUniversity Medical Center Goettingen·N/A·NCT05817721·893 enrolled
Short Incubation Methylaminolevulinate Photodynamic Therapy Without Occlusion
Completed·IInnovaderm Research Inc.·Phase 3·NCT00926952·20 enrolled
The Impact of NBP on the Collateral Circulation in ICA/M1 Occlusion
Completed·SSecond Affiliated Hospital, School of Medicine, Zhejiang University·Phase 4·NCT02594995·311 enrolled
Effect of LOW-molecular-weight Heparin in Reducing Radial Artery Occlusion Rate After Transradial Coronary Catheterization
Completed·—·Phase 4·NCT04196309·60 enrolled
A Dose Escalation and Safety Study of Plasmin (Human) In Acute Lower Extremity Native Artery or Bypass Graft Occlusion
Completed·Grifols Therapeutics LLC logoGrifols Therapeutics LLC·Phase 1·NCT00418483·83 enrolled
Intraarterial Nitroglycerin Versus Nicardipine and Radial Artery Occlusion
Completed·HHermina Heart Center Kemayoran·Phase 3·NCT03622060·600 enrolled
Argatroban for Preventing Occlusion and Restenosis After Extracranial Vertebral Artery Stenting
Completed·—·Phase 4·NCT01980316·114 enrolled
Nitroglycerin Prevents Radial Artery Occlusion
Completed·NNational Cardiovascular Center Harapan Kita Hospital Indonesia·N/A·NCT02105493·1,706 enrolled
Argatroban for Preventing Occlusion and Restenosis After Intracranial and Extracranial Artery Stenting
Completed·JJinling Hospital, China·Phase 4·NCT01163604·114 enrolled
Endovascular Recanalization and Standard Medical Management for Symptomatic Nonacute Intracranial Artery Occlusion Trial
Completed·—·Phase 1·NCT04864691·453 enrolled
Collagenase Total Occlusion-1 Trial
Completed·SSunnybrook Health Sciences Centre·Phase 1·NCT01271335·28 enrolled
Subcutaneous Nitroglycerin to Prevent Radial Artery Occlusion in Children
Completed·SSeoul National University Hospital·N/A·NCT05443061·200 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)